PRDM1 anticorps
-
- Antigène Voir toutes PRDM1 Anticorps
- PRDM1 (PR Domain Containing 1, with ZNF Domain (PRDM1))
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp PRDM1 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC)
- Purification
- Protein G Chromatography
- Immunogène
- This PRDM1 / BLIMP1 antibody was raised against full-length recombinant human PRDM1 / BLIMP1 protein.
- Clone
- ROS195
- Isotype
- IgG1
- Top Product
- Discover our top product PRDM1 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Concentration
- 1 μg/μL
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles and keep on ice when not in storage.
- Stock
- -20 °C
- Stockage commentaire
- Antibodies in solution can be stored at -20 °C for 2 years.
- Date de péremption
- 6 months
-
-
MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas." dans: The American journal of pathology, Vol. 173, Issue 1, pp. 242-52, (2008) (PubMed).
: "PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor." dans: Blood, Vol. 111, Issue 7, pp. 3867-71, (2008) (PubMed).
: "Rituximab plus CHOP (R-CHOP) overcomes PRDM1-associated resistance to chemotherapy in patients with diffuse large B-cell lymphoma." dans: Blood, Vol. 110, Issue 1, pp. 339-44, (2007) (PubMed).
: "PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma." dans: Haematologica, Vol. 91, Issue 4, pp. 467-74, (2006) (PubMed).
: "[Malignant fibrous histiocytoma of soft tissues: early report of 10 cases]." dans: Medicina clínica, Vol. 97, Issue 7, pp. 279, (1991) (PubMed).
: "
-
MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas." dans: The American journal of pathology, Vol. 173, Issue 1, pp. 242-52, (2008) (PubMed).
-
- Antigène
- PRDM1 (PR Domain Containing 1, with ZNF Domain (PRDM1))
- Autre désignation
- PRDM1 / BLIMP1 (PRDM1 Produits)
- Synonymes
- anticorps GB11750, anticorps CG5249, anticorps Dmel\\CG5249, anticorps blimp-1, anticorps dBlimp-1, anticorps dBlimp1, anticorps Blimp-1, anticorps Blimp1, anticorps nrd, anticorps prdm1, anticorps ubo, anticorps wu:fb99c12, anticorps zgc:91885, anticorps MGC52536, anticorps PRDM1, anticorps blimp1, anticorps xblimp1, anticorps prdi-bf1, anticorps BLIMP1, anticorps PRDI-BF1, anticorps ZNFPR1A1, anticorps PR/SET domain 1, anticorps probable serine/threonine-protein kinase DDB_G0282963, anticorps CG5249 gene product from transcript CG5249-RF, anticorps blimp-1, anticorps PR domain containing 1a, with ZNF domain, anticorps PR domain 1 S homeolog, anticorps B lymphocyte induced maturation protein 1, anticorps PR domain 1, anticorps PR domain containing 1, with ZNF domain, anticorps PRDM1, anticorps LOC408295, anticorps Blimp-1, anticorps CpipJ_CPIJ007425, anticorps prdm1a, anticorps prdm1.S, anticorps prdm1, anticorps Prdm1
- Poids moléculaire
- 77 & 95 kDa
- ID gène
- 639
- Pathways
- Regulation of Muscle Cell Differentiation
-